The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.

A real-world study reveals the need for increased homologous repair deficiency and BRCA1/2 testing in patients with ovarian ...

Although Eisai decided not to option a HER2-targeted drug under a deal with BlissBio, Angle wants to keep working with the firms to advance its CTC technology.

Don't just go by your provider's promise on broadband speed. Use the Which? free speed test to investigate. Here we explain how to use the speed checker. If your broadband isn't as fast as it should ...

A blood glucose test measures how much sugar you have in your blood. You may have a blood glucose test in a doctor’s office, laboratory, or with a fingerstick meter at home. When you eat ...

These blood tests can be used to measure the amount of sugar (glucose) in your blood: A1C (glycated hemoglobin) test fasting plasma glucose test random plasma glucose test oral glucose tolerance ...

For the primary end point of assessing changes in therapeutic modifications following HER2DX testing, data showed that 56.2% of these adjustments involved reducing chemotherapy, 26.7% involved ...

Sony has developed an AI prototype for Horizon's Aloy to engage in conversation with users using advanced tech. Key players in the gaming industry are actively developing AI-based models and ...

Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies ... in 624 patients with ER+/HER2- advanced or metastatic breast ...

When not testing the latest phones, he can normally be found with his camera in hand, behind his drums or eating his stash of home-cooked food. Sometimes all at once. But it's 2025 now and the ...

The test comes after Williams formally asked a judge to end her guardianship last month. According to TMZ, caregiver Gina Monterroso—who is not connected to Williams' guardianship—sent a ...

Credit: Shutterstock / Maria Sbytova. Pharma giant Pfizer and Arvinas’s human epidermal growth factor receptor 2 (HER2) negative breast cancer therapy, vepdegestrant, has seen mixed results after it ...